sterilisation there is a risk of infection. Diabetics commonly keep their syringes in spirit although similar practices have been abandoned in hospital, where sterile instruments are now stored dry. It would seem logical for diabetics to store their syringes-glass or plastic-in the same way. Thirty patients reported by Greenough et a13 used a single plastic syringe, stored dry in a domestic refrigerator, for up to two months without infection. Nevertheless, using a new needle, as these patients did, does not eliminate the risk of infection since the syringe nozzle may become infected when an infected needle is removed. 4 The ideal solution would be for diabetics to use a new sterilised syringe and needle for each injection. But the bacteriological risk is clearly small and is not the only consideration. It must be balanced against the cost of meeting it.
Inman PM, Beck A, Brown AE, Stanford JL. Outbreak Phenylbutazone poisoning is uncommon and apparently has not been reported in the United Kingdom. We report the case of a patient with very abnormal phenylbutazone metabolism in whom hepatic and renal damage occurred.
Case report
A previously healthy 17-year-old girl was admitted 16 hours after allegedly taking 40 phenylbutazone tablets (8 g). She did not drink alcohol or take any drugs regularly and the tablets had belonged to her mother. The patient initially fell asleep but woke feeling very unwell with severe nausea. On examination she was drowsy with nystagmus. Intravenous fluids were started because of persistent vomiting. The next morning she developed a sinus tachycardia (120/min) and was hyperventilating with a respiratory aLkalosis (arterial H+ 32 nmol/l (pH 7.49), Pco2 2 9 kPa (22 mm Hg), and bicarbonate 17 mmol(mEq)/l). Malaise, drowsiness, and vomiting continued for three days, when jaundice appeared with biochemical evidence of liver damage (figure). The maximum plasma bilirubin concentration, alanine aminotransferase activity, and alkaline phosphatase concentration were 125 ,umol/l (7-4 mg/100 ml), 471 U/1, and 136 U/l on the 4th, 6th, and 8th days respectively. Tests for hepatitis B surface antigen and antibody were negative and there was no evidence of haemolysis or other haematological toxicity. The plasma albumin concentration remained within normal limits and there was no clinical evidence of fluid retention. Despite adequate fluid replacement there was early but transient impairment of renal function with proteinuria, a reduction in creatinine clearance to 34 ml/min, and a raised plasma urea concentration (figure).
The patient subsequently improved and was discharged on the sixth day, although liver function tests were still abnormal at follow-up nine days later. Serial plasma concentrations of phenylbutazone and its metabolites oxyphenbutazone and y-hydroxyphenylbutazone were measured simultaneously by high performance liquid chromatography.' The initial plasma phenylbutazone concentration was grossly raised at 670 ,g/ml and the half life, normally about three days, was very short at 23 hours. In contrast to the pattern of metabolites in plasma after therapeutic doses of phenylbutazone2 the relative proportions of oxyphenbutazone and y-hydroxyphenylbutazone were reversed, with the former disappearing rapidly and high concentrations of the latter, which rapidly exceeded those of the parent drug (figure).
Comment
The clinical features in this patient resembled those described in the few previous reports of phenylbutazone intoxication, although jaundice does not always occur. Convulsions and gastrointestinal perforation have also been reported. [3] [4] [5] respectively of the total in plasma, and the maximum for y-hydroxyphenylbutazone was 6%. Thus in our patient the pattern of metabolites was completely reversed. Possible explanations include greatly increased production of y-hydroxyphenylbutazone, concentrationdependent saturation of aromatic hydroxylation, and impaired renal excretion of the y-hydroxy metabolite. The kinetics, however, were not consistent with saturation, and increased y-hydroxylation seems the most likely cause in view of the unusually short half life of the parent drug. The hepatotoxicity of phenylbutazone may be mediated through metabolic activation (as with paracetamol), and we are tempted to postulate a relationship between abnormal metabolism of the drug in this patient and subsequent liver damage. Examination showed pallor, and painless small rubbery lymphadenopathy in the groin, axilla, and neck. The spleen was enlarged four centimetres below the left costal margin. A subcapital fracture dislocation of the left hip and a fracture of the neck and shaft of right femur were also detected.
Osteoporotic areas and possible lytic lesions were seen around the fracture sites. The haemoglobin concentration was 9 3 g/dl and the white blood cell count 28-0 x 109/1 (28 000/mm3) with 7 % smear cells and 78 % small mature lymphocytes. Biochemical investigations showed a serum calcium concentration of 3 9 mmol/l (15-6 mg/100 ml), serum phosphate concentration of 1-7 mmol/l (5-6 mg/100 ml), serum alkaline phosphatase activity of 15 KA units, and serum albumin concentration of 38 g/l. Serum parathyroid hormone concentration was 0-25 ng/ml (normal < 1-0 ng/ml).
Examination of a lymph-node biopsy sample taken from the neck showed infiltration with lymphocytic cells. Studies on the lymphocytes showed the presence on the cell surface of both immunoglobulin M and immunoglobulin D. The cells were monoclonal B cells, expressed receptors for mouse erythrocytes, and formed rosettes. Surface marker studies were performed simultaneously on peripheral circulating lymphocytes, which expressed closely similar patterns. These results are diagnostic of chronic lymphocytic leukaemia.1 A bone scan (using technetium methylene diphosphonate) displayed areas of high uptake at the fracture sites and also in the ribs and vertebrae. Examination of marrow aspirate showed reduced granulopoiesis and thrombopoiesis plus 93 % mature small lymphocytes-similar to those found in the peripheral circulation.
A left Thomson's hip prosthesis was inserted. The femoral head was removed and sent for histological examination; the tissue removed from the femoral head was identical with that in the lymph-node biopsy sample, and there was no evidence of any other neoplastic cell type. Histological examination of the affected bone showed large numbers of osteoclasts around the tumour cell mass. Treatment of the hypercalcaemia was started with oral phosphate Phosphate-Sandoz; 0 5 g three times daily) followed by oral 3-amino-l-hydroxypropylidene 1-biphosphate (370 mg three times daily, then 125 mg three times daily). Hypercalcaemia was reversed by both treatments (figure). Two weeks after surgery the patient was given chlorambucil 5 mg/day for four weeks. With this treatment the abnormal peripheral blood changes were completely reversed. The response in white blood cell count was dramatic. Treatment ofhypercalcaemia was accompanied by symptomatic improvement, return of appetite, reduced thirst, and reduced frequency of micturition. The patient remained normocalcaemic for over six weeks without treatment and was able to return home to lead a normal life style.
Hypercalcaemia and bony spread in chronic lymphocytic leukaemia is a rare association, and in all reported cases there does not appear to have been histological confirmation of bony spread.
The above changes are well described in myeloma and other lymphoproliferative disorders, but our histology and surface marker studies indicate that this patient had chronic lymphocytic leukaemia. Another feature was the large number of osteoclasts seen around the tumour mass. The appearances lend support to the existence of an osteocIast activating factor released by neoplastic cells of the tumour mass. Release of this factor has been shown in cells of lymphosarcoma type by Mundy et a12 but not before in a patient with chronic lymphocytic leukaemia.
Interestingly, in a similar case Laugen et a13 found raised immunoreactive parathyroid hormone concentrations. In our case parathyroid hormone concentrations were normal. In several other reported cases parathyroid hormone concentrations have not been raised except in the presence of renal failure.
We therefore suggest that in this patient the hypercalcaemia was probably due to secretion of osteoclast activating factor by malignant lymphocytes, as the degree of hypercalcaemia seen in this case'would be difficult to explain on the basis of fractures and subsequent immobility in an elderly patient with slow bone turnover rate and in the absence of Paget's disease.
